☰
The companies are using a proprietary technology to track specific conversations regarding COVID-19 The transaction marks W2O’s fifth purchase in nine months with Symplur now operating under the name of W2O Symplur W2O- a....
One Drop, a leading digital health company, has recently announced the acquisition of the whole assets & intellectual property of Sano Intelligence Inc., a developer of wearable sensors. Several team members of Sano will join the compan....
The study aims at analyzing the tolerability and safety of ATG-019 monotherapy or in combination with niacin ER Antengene is also exploring the potential of ATG-019 in the treatment of various other indications Antengene has reportedly....
The medical technology company has received Breakthrough Device Designation by the FDA for its Oxygen Assist Module (OAM). The OAM module is commonly used with most versions of Vapotherm’s Precision Flow systems. A global medica....
Polaryx Therapeutics, Inc., a developer of drug candidates for lysosomal storage disorders, has recently gained IND (Investigational New Drug Application) approval from the U.S. FDA. This approval is related to the study of PLX-200 treatmen....
RTI International has recently closed the acquisition of MDA (Medical Data Analytics), an RWE (real-world evidence) generation provider to the pharmaceutical & biotechnology industry. Medical Data Analytics employs verified and screene....
Another potential COVID-19 vaccine has recently received FDA approval to commence clinical trials among humans. The vaccine, developed by Inovio Pharmaceuticals and backed by Melinda and Bill Gates, is the second such vaccine to progress to....
LSU Health, a renowned public university focused on health sciences, has now reportedly become one of the first centers of the U.S. to start the enrollment of coronavirus patients in a global trial to test the use of nitric oxide to enhance....
CSC, a leading firm providing legal, tax, as well as digital and business services across the world, has recently announced that it has finished its acquisition of TCS-Groep, a service provider of alternative investment funds (AIFs), based ....
Evotec gains access to panCELLa’s iPS cell lines known as- iACT Stealth Cells™ The company will also gain control over FailSafe™- a iPSC derived cell therapy Evotec SE- a Germany based biotechnology firm has reported....
